You may need better control
of your asthma if you:6
- Experience symptoms more than 2 days/week
- Use a reliever inhaler for symptoms more than 2 days/week
- Experience any activity limitation due to your asthma
- Experience night waking due to your asthma
Not sure if your asthma is under control?
Answer four simple questions to find out if your asthma symptoms are well controlled. You can talk to your doctor about your results and discuss what steps you can take to improve control.
What are the risks if your asthma is not well controlled?5
Studies have shown that using only a reliever inhaler is associated with:
- Increased risk of asthma attack
- Shortness of breath
This is because it’s not treating your airway inflammation, which is an underlying cause of asthma symptoms.
Also, if you are using three or more reliever inhaler canisters per year, this can increase the risk of asthma attacks.6
Talk to your doctor about how you can get your asthma under control.
Breathe easier - today and tomorrow*
*Asthma anti-inflammatory reliever and preventer in a single inhaler.1,2
Most reliever inhalers treat the immediate symptoms of asthma but don’t address the longer-term issue, inflammation in the airways. Does your current inhaler do both?
Find out more about how Symbicort works and whether it could be right for you.
Want to learn more about asthma?
Download our Quick Guide to asthma and Symbicort.
This visual snapshot is a guide to understanding asthma and how Symbicort can help. Share this with your doctor to discuss.
Symbicort® Prescription Medicine. For relief of and/or regular treatment of asthma. Symbicort® has risks and benefits. Budesonide/formoterol 100/6, 200/6. For product information check with your doctor or Consumer Medicine Information on www.medsafe.govt.nz www.medsafe.govt.nz. Click for further details. AstraZeneca (NZ) Ltd. Auckland.
Ready to learn more about Symbicort? Talk to your doctor today.
USEFUL LINKS:
This site is intended for New Zealand consumers only.
Keep using your asthma medication as prescribed by your doctor until they tell you to change. Your doctor may prescribe Symbicort Turbuhaler in a different way or for a different indication to that which is described here. Follow your doctors directions carefully. Usually you do not feel any side effects when you use Symbicort. The most common side effects of Symbicort are mild irritation in the throat, coughing, hoarseness, thrush (of mouth or throat), headache, tremor, palpitations and pneumonia (in COPD patients). Tell your doctor if any of these or other unusual effects bother you.
Symbicort® is a prescription medicine for the treatment of asthma and COPD. For asthma: Anti-inflammatory reliever therapy (Symbicort 200/6); Anti-inflammatory reliever plus maintenance therapy (Symbicort 100/6; 200/6), maintenance therapy (Symbicort 100/6, 200/6, 400/12). For COPD (Symbicort 200/6, 400/12). Symbicort® has risks and benefits. Ask your doctor if Symbicort® is right for you. Use strictly as directed. If symptoms persist see your doctor. Symbicort® is fully funded on the Pharmaceutical Schedule. Normal doctor’s charges and pharmacy fees apply. Ingredients: budesonide/formoterol 100mcg/6mcg, 200/mcg/6mcg, 400mcg/12mcg. For product details check the Consumer Medicine Information, CMI, at www.medsafe.govt.nz.
References: 1. SYMBICORT Turbuhaler Consumer Medicine Information. Available from https://www.medsafe.govt.nz/Consumers/cmi/s/SymbicortThaler.pdf. Last accessed June 2022. 2. SYMBICORT Turbuhaler Data Sheet NZ. 3. National Asthma Council (NAC). Australian Asthma Handbook V2.1. Guide to Reliever Medicines. 2020. Available at: https://www.asthmahandbook.org.au/resources/medicines-guide/relievers. Last accessed 09 September 2020. 4. Asthma and Respiratory Foundation NZ. What is Asthma? Available from https://www.asthmafoundation.org.nz/your-health/living-with-asthma. Last accessed on 9 December 2019. 5. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2022. Available from https://ginasthma.org/wp-content/uploads/2022/05/GINA-Main-Report-2022-FINAL-22-05-03-WMS.pdf . Last accessed June 2022. 6. Asthma and Respiratory Foundation NZ: NZ Adolescent and Adult Asthma Guidelines 2020. Available from https://www.nzrespiratoryguidelines.co.nz/uploads/8/3/0/1/83014052/arfnz_adolescent_and_ad ult_asthma_guidelines_.pdf. Last accessed 24 July 2020. 7. Asthma and Respiratory Foundation NZ. Reliever Inhalers. Available from https://www.asthmafoundation.org.nz/your-health/living-with-asthma/asthma-medication/reliever-inhalers. Last accessed on 3 June 2019. 8. SYMBICORT Turbuhaler NZ Instructions for Use.
Symbicort®, Turbuhaler® and Bricanyl® are trademarks of the AstraZeneca Group of companies. Ventolin® is a registered trademark of the GSK group of companies. SalAir® is a registered trademark of Rex Medical. Respigen™ is a trademark of Mylan. Registered user AstraZeneca Limited, PO Box 87453, Meadowbank, Auckland 1742.
For Medical Information enquiries or to report an adverse event or product quality complaint: Telephone 0800 684 432 or (09) 306 5650 or via https://contactazmedical.astrazeneca.com.
September 2026, NZ-2634, TAPS DA2504JL, INDE14381.
Quiz code are